LRB08
KUe008-A
General
iPSC Line |
|
| hPSCreg name | KUe008-A |
| Cite as: | KUe008-A (RRID:CVCL_B243) |
| Alternative name(s) |
LRB08
|
| iPSC line type | Human embryonic stem cell (hESC) |
| Similar iPSC lines | No similar lines found. |
| Last update | 30th August 2022 |
| User feedback | |
Provider |
|
| Generator |
University of Copenhagen (KU)
Contact:
Laboratory of Reproductive Biology |
| Derivation country | Denmark |
External iPSC Databases |
|
| Cellosaurus | CVCL_B243 |
| Wikidata | Q54903016 |
General iPSC Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | |
Ethics
| Alternatives to consent are available? | Yes |
| Alternatives to consent | |
| Alternative consent approval number | |
| How may genetic information associated with the cell line be accessed? |
hESC Derivation
| Date of derivation | 2006-05-14 |
| Embryo stage | Blastula with ICM and Trophoblast |
| Supernumerary embryos from IVF treatment? |
Yes
|
| PGD Embryo? |
No |
| Expansion status |
4
|
| ICM morphology |
C
|
| Trophectoderm morphology |
b
|
| ZP removal technique | Mechanical |
| Cell isolation | Mechanical |
| Cell seeding | Isolated ICM |
iPSC Culture Conditions
| Feeder cells |
Yes |
||||||
| Passage method | Mechanically | ||||||
| O2 Concentration | 6,9 % | ||||||
| CO2 Concentration | 5 % | ||||||
| Medium |
Other medium:
Base medium: Knockout-DMEM
Main protein source: Knock-out serum replacement Serum concentration: 15 % Supplements
|
iPSC Characterisation
Analysis of undifferentiated iPSCs
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| NANOG |
Yes |
|
|
|||
| POU5F1 (OCT-4) |
Yes |
|
|
|||
| SOX2 |
Yes |
|
||||
| DNMT3B |
Yes |
|
||||
| GABRB3 |
Yes |
|
||||
| GDF3 |
Yes |
|
||||
| TDGF1 |
Yes |
|
Genotyping
Karyotyping (iPSC Line) |
|
| Has the iPSC line karyotype been analysed? |
Yes
|
Other Genotyping (iPSC Line) |
|
Login to share your feedback, experiences or results with the research community.